Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Key Record Dates Identifier: NCT02644967
Brief Title: A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma (ILLUMINATE-204)

First Submitted : December 23, 2015
First Submitted that Met QC Criteria : December 31, 2015
First Posted : January 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 9, 2020
Last Update Posted : January 13, 2020